A novel therapeutic strategy for osteosarcoma using anti-GD2 ADC and EZH2 inhibitor
2025 · Biomarker Research · 3 citations
https://doi.org/10.1186/s40364-025-00800-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
222
Citations
8
h-index
7
i10-index
Jiaming Cui is an academic researcher from Ningbo University. The author has contributed to research in topics: Shoulder Injury and Treatment & Legal and Regulatory Analysis & Linguistic, Cultural, and Literary Studies. The author has an h-index of 8, co-authored 34 publications.
https://doi.org/10.1186/s40364-025-00800-3
https://doi.org/10.1038/s41598-025-04359-9
Click to start Chat